
Aroa Biosurgery Ltd
ASX:ARX

Intrinsic Value
The intrinsic value of one
ARX
stock under the Base Case scenario is
1.197
AUD.
Compared to the current market price of 0.405 AUD,
Aroa Biosurgery Ltd
is
Undervalued by 66%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Aroa Biosurgery Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Aroa Biosurgery Ltd
Balance Sheet Decomposition
Aroa Biosurgery Ltd
Current Assets | 64m |
Cash & Short-Term Investments | 21.9m |
Receivables | 29.1m |
Other Current Assets | 13m |
Non-Current Assets | 41.7m |
PP&E | 22.3m |
Intangibles | 19.3m |
Other Non-Current Assets | 93k |
Free Cash Flow Analysis
Aroa Biosurgery Ltd
NZD | |
Free Cash Flow | NZD |
Earnings Waterfall
Aroa Biosurgery Ltd
Revenue
|
76.4m
NZD
|
Cost of Revenue
|
-10.2m
NZD
|
Gross Profit
|
66.1m
NZD
|
Operating Expenses
|
-76m
NZD
|
Operating Income
|
-9.9m
NZD
|
Other Expenses
|
2.3m
NZD
|
Net Income
|
-7.6m
NZD
|
ARX Profitability Score
Profitability Due Diligence
Aroa Biosurgery Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Score
Aroa Biosurgery Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
ARX Solvency Score
Solvency Due Diligence
Aroa Biosurgery Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Score
Aroa Biosurgery Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ARX Price Targets Summary
Aroa Biosurgery Ltd
According to Wall Street analysts, the average 1-year price target for
ARX
is 0.863 AUD
with a low forecast of 0.758 AUD and a high forecast of 0.977 AUD.
Dividends
Current shareholder yield for ARX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ARX
stock under the Base Case scenario is
1.197
AUD.
Compared to the current market price of 0.405 AUD,
Aroa Biosurgery Ltd
is
Undervalued by 66%.